Disodium 5'-O-[({hydroxy[(hydroxyphosphinato)oxy]phosphoryl}oxy)phosphinato]cytidine(CAS: 81012-87-5)

Disodium 5'-O-[({hydroxy[(hydroxyphosphinato)oxy]phosphoryl}oxy)phosphinato]cytidine (CAS: 81012-87-5) falls under the regulatory framework of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. It is also subject to the European Union's Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) regulations. Additionally, the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) may have specific guidelines and requirements for handling and use in pharmaceutical and environmental contexts.

There are several alternatives to Disodium 5'-O-[({hydroxy[(hydroxyphosphinato)oxy]phosphoryl}oxy)phosphinato]cytidine (CAS: 81012-87-5) in synthesis, including other nucleoside analogs and phosphoramidites. These alternatives offer different functional groups and reactivity profiles, which can be chosen based on the specific needs of the synthesis process.

The market for Disodium 5'-O-[({hydroxy[(hydroxyphosphinato)oxy]phosphoryl}oxy)phosphinato]cytidine (CAS: 81012-87-5) is growing due to its potential applications in DNA and RNA research. Research trends indicate a focus on its use in gene therapy, drug delivery systems, and as a component in nucleic acid-based diagnostics. Market dynamics show increasing demand from academic and industrial research sectors.

Waste containing Disodium 5'-O-[({hydroxy[(hydroxyphosphinato)oxy]phosphoryl}oxy)phosphinato]cytidine (CAS: 81012-87-5) should be collected in appropriate containers, labeled, and disposed of according to local hazardous waste regulations. Incineration is a common method, but professional waste disposal services are recommended to ensure compliance with environmental protection standards. Proper handling includes avoiding contact with skin and eyes, and wearing appropriate personal protective equipment (PPE).